Dyax, CMIC in deal for ecallantide in Japan

Dyax Corp. (NASDAQ:DYAX) granted CMIC Co. Ltd. (Tokyo:2309) exclusive rights in Japan to develop and commercialize ecallantide ( DX-88) to treat hereditary angioedema (HAE) and other angioedema indica...